Press Archive - Page 5 of 33 - Stand Up to Cancer


Read the latest Stand Up To Cancer press releases and announcements to see how we are making an impact.


December 4, 2017

Genentech, American Cancer Society, Stand Up To Cancer, and Rally Health on Cancer Screen Week

Genentech, a member of the Roche Group, the American Cancer Society (ACS), Stand Up To Cancer and Rally Health, today announced a new public health initiative called “Cancer Screen Week” urging every American to join together to make a difference in the fight against cancer by pledging to get their recommended cancer screenings. According to ACS, screening significantly increases the chances of detecting certain cancers early, when they are most likely to be treated successfully. Every pledge increases the potential impact “Cancer Screen Week” can have on saving more lives from cancer. This year, “Cancer Screen Week” will take place December 4-8, 2017, and annually thereafter the first week of December.
Read More
October 27, 2017

Stand Up To Cancer And Major League Baseball Hit Home With Powerful New PSA – “Whatever It Takes”

Stand Up To Cancer (SU2C) is set to launch a new public service announcement (PSA) campaign in collaboration with SU2C Founding Donor Major League Baseball. The PSA, titled “Whatever It Takes,” features Major League players and moments from MLB’s Championship Season that underscore the message that the end of the fight against cancer is unlikely to come from a single “home run,” but rather will be the result of numerous and smaller, yet meaningful, scientific advancements that keep the fight moving forward. The broadcast PSA will debut Saturday, Oct. 28, during Game Four of the 2017 World Series. Continuing a proud tradition that launched in 2011, the 113th Fall Classic will feature a moving tribute in the form of the “SU2C Placard Moment” following the end of the 5th inning. Thousands of fans in the ballpark will hold cards to honor those currently in the fight or who have been lost to cancer. MLB and its 30 Clubs are the founding donors of SU2C, committing $43 million to date to SU2C’s innovative cancer research.
Read More
October 26, 2017

Stand Up To Cancer Launches Four Teams on “Cancer Interception” To Detect Cancer at Earliest Stages

Stand Up To Cancer (SU2C), joined by the Lustgarten Foundation for Pancreatic Cancer Research, LUNGevity, and the American Lung Association, announced today four teams of top researchers who will carry out an attack on cancers of the lung and pancreas using a radical new approach of “interception” of cancers at very early stages, when they can be more successfully treated.
Read More
October 20, 2017

Jimmy Smits Joins Stand Up To Cancer In New Public Service Announcement

Stand Up To Cancer (SU2C) has created a new cancer immunotherapy public service announcement (PSA) campaign, supported by a charitable donation from Bristol-Myers Squibb Company, and featuring award-winning actor and SU2C Ambassador Jimmy Smits. The print, TV, radio, out-of-home and digital PSAs will begin airing in October.
Read More
October 12, 2017

10 SU2C Catalyst Clinical Trials Launched

Stand Up To Cancer (SU2C) has awarded 10 SU2C Catalyst® clinical trial projects in which researchers from more than 30 institutions collaborate across academic and corporate borders on clinical trials—with correlated translational research which will deepen our understanding of why treatments are effective—across a variety of cancers, in a program supported by industry. The inaugural SU2C Catalyst projects will explore new uses for an array of powerful medicines, from the three SU2C Catalyst Charter Supporters and six other pharmaceutical companies, the American Association for Cancer Research, SU2C’s Scientific Partner, announced today.
Read More
September 12, 2017

SU2C and PBS Open Applications for 2018 Emperor Science Award Program

Stand Up To Cancer (SU2C), a division of the Entertainment Industry Foundation, and PBS announced today the opening of applications for The Emperor Science Award 2018 program. The program is designed to empower high school students to become the next generation of cancer researchers through a unique mentoring opportunity. Through this initiative, 100 winning students will each get to work with an esteemed university-level research scientist on a rewarding multi-week cancer research project.
Read More
August 30, 2017


Actress and Stand Up To Cancer Ambassador Jaime King is teaming up with Stand Up To Cancer (SU2C) and Rally Health to get the word out about sunscreen and skin cancer prevention.
Read More
July 27, 2017

New SU2C-Lustgarten Foundation Research Team Aims To Apply CAR T-cell Therapy to Pancreatic Cancer

Stand Up To Cancer (SU2C) is supporting a new translational research team to explore how a type of immunotherapy that has been very successful in blood cancers can be applied to pancreatic cancer, the American Association for Cancer Research, SU2C’s Scientific Partner, announced today.
Read More
July 12, 2017

Stand Up To Cancer, St. Baldrick’s Foundation Hail Green Light for CAR T Cell Therapy for Leukemia

Stand Up To Cancer and the St. Baldrick’s Foundation welcomed the Oncology Drugs Advisory Committee’s (ODAC) strong recommendation for approval by the Food and Drug Administration (FDA) of a revolutionary new therapy for a deadly form of leukemia, an approach whose development has also been supported by SU2C and St. Baldrick’s.
Read More
June 13, 2017

Stand Up To Cancer Announces Open Call for Ideas for $10 Million Dream Team of Top Investigators

Stand Up To Cancer (SU2C) is inviting proposals for a new $10 million Dream Team of top scientific investigators searching for new strategies to prevent or treat cancer, the American Association for Cancer Research (AACR), SU2C’s Scientific Partner, announced today.
Read More


Sign up to receive emails from Stand Up To Cancer.
   Please leave this field empty
Stand Up to Cancer

Thanks for signing up!
You will hear from us soon.

Donate to SU2C using your Mastercard, and Mastercard will match up to $250,000 from 12/10 through 12/31, or until match is fulfilled.* Learn How